8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
2016 / Randomized, double-blind, placebo-controlled trial
A 1-year randomized, double-blind, placebo-controlled study evaluated telomere length changes with the dietary supplement TA-65 in 117 CMV-positive subjects aged 53-87 years. Subjects taking a low dose of TA-65 (250 U) significantly increased telomere length over 12 months (530 ± 180 bp; p = 0.005), whereas the placebo group experienced significant telomere loss (290 ± 100 bp; p = 0.01). The high-dose group (1000 U) showed a trend toward improvement compared to placebo that did not reach statistical significance.
Salvador L, Singaravelu G, Harley CB, et al. Rejuvenation Res, 2016. PMID 26950204
2016 / Randomized controlled trial
In the PREDIMED-NAVARRA trial, 520 participants at high cardiovascular risk were randomized to a low-fat control diet, a Mediterranean diet with extra virgin olive oil (MeDiet-EVOO), or with nuts (MeDiet-nuts) for 5 years. Baseline MeDiet adherence was linked to longer basal telomeres in women (score >=10: 0.27 vs. score <=6: -0.46, P=0.003) but the opposite in men (P interaction = 0.036). After 5 years, allocation to MeDiet-nuts was associated with greater telomere shortening (-0.24, 95% CI: -0.38 to -0.01; P=0.003), while MeDiet-EVOO showed no significant difference compared to control (P=0.537).
García-Calzón S, Martínez-González MA, Razquin C, et al. Clin Nutr, 2016. PMID 27083496
2016 / 12-month randomized, placebo-controlled, double-blind trial
A 12-month randomized, placebo-controlled, double-blind study evaluated the effect of 1500 mg/d BiocurcumaxTM versus placebo in 96 community-dwelling older adults. A significant time×treatment interaction was detected for the Montreal Cognitive Assessment (F=3.85, P<0.05), driven by a decline in function in the placebo group at 6 months that was not seen in the curcumin group. No differences between the groups were observed for all other clinical and cognitive measures.
Rainey-Smith SR, Brown BM, Sohrabi HR, et al. Br J Nutr, 2016. PMID 27102361
2016 / Double-blind, placebo-controlled, balanced crossover trial
In a balanced crossover trial, 36 adults with type 2 diabetes consumed single doses of synthetic trans-resveratrol (0, 75, 150, and 300 mg) at weekly intervals. CVR to a hypercapnic stimulus was assessed by transcranial Doppler ultrasound before and 45 minutes after treatment. Resveratrol increased CVR in the middle cerebral arteries, with mean within-individual changes from placebo of 13.8 ± 3.5% for 75 mg (P = 0.001), 8.9 ± 3.5% for 150 mg (P = 0.016), and 13.7 ± 3.3% for 300 mg (P < 0.001). Only the 75 mg dose significantly increased CVR in the posterior cerebral arteries (13.2 ± 4.5%, P = 0.016).
Wong RH, Nealon RS, Scholey A, et al. Nutr Metab Cardiovasc Dis, 2016. PMID 27105868
2016 / Comparative tissue analysis and animal intervention study
Investigators compared hepatic NAD(+) and NAD(+) biosynthesis enzymes in middle-aged and aged mice and patients, and tested the effects of high-fat diet and nicotinamide riboside in DN-NAMPT transgenic mice. Hepatic NAD(+) levels decreased in aged mice and humans, with compromised NAMPT-controlled NAD(+) salvage. Middle-aged DN-NAMPT mice fed normal chow displayed systemic NAD(+) reduction and moderate NAFLD phenotypes, which deteriorated under a high-fat diet. Oral administration of nicotinamide riboside completely corrected these NAFLD phenotypes.
Zhou CC, Yang X, Hua X, et al. Br J Pharmacol, 2016. PMID 27174364
2016 / Randomized parallel-group trial and pilot crossover trial
Researchers evaluated the efficacy of an oral combination of rosemary and grapefruit extracts in decreasing UV radiation-induced skin damage and improving signs of aging. In a randomized parallel-group trial of 90 women and a pilot crossover trial of 5 women, treated participants showed decreased skin redness and lipoperoxides following UV exposure, along with improvements in skin wrinkledness and elasticity. No differences were observed between 100 mg and 250 mg doses, indicating a plateau effect starting at 100 mg, with some benefits appearing as early as 2 weeks.
Nobile V, Michelotti A, Cestone E, et al. Food Nutr Res, 2016. PMID 27374032
2016 / Double-blind, placebo-controlled randomized clinical trial
A total of 417 elderly patients with an acute distal radius fracture were randomized to receive skimmed milk containing either Lactobacillus casei Shirota or placebo daily for 6 months. Throughout the study, patients receiving probiotics showed a significantly faster pace of improvement in DASH score, pain, CRPS score, wrist flexion, and grip strength compared to placebo. Treatment outcomes for the probiotic group at month 4 were comparable to levels seen in the placebo group at month 6.
Lei M, Hua LM, Wang DW Benef Microbes, 2016. PMID 27633174
2016 / Secondary analysis of a randomized controlled trial
This secondary analysis of the ATBC study examined the effect of 50 mg/day of vitamin E for 5-8 years on pneumonia incidence in 7,469 male smokers. Among 2,216 participants who smoked 5-19 cigarettes/day at baseline and exercised at leisure time, vitamin E reduced pneumonia incidence by 69% (95% CI: 43%-83%), preventing pneumonia in 12.9% by age 74. Among the remaining 5,253 participants, incidence was 14% lower (95% CI: -38% to +21%). In participants who quit smoking for a period, vitamin E reduced pneumonia incidence by 72% (95% CI: 31%-89%), including those who smoked >=20 cigarettes/day at baseline or did not exercise.
Hemilä H Clin Interv Aging, 2016. PMID 27757026
2016 / Randomized, double-blind, controlled clinical trial
Sixty patients with Alzheimer's disease were randomized to receive 200 ml/day of control milk or probiotic milk containing Lactobacillus acidophilus, L. casei, Bifidobacterium bifidum, and L. fermentum for 12 weeks. Compared to controls (-5.03% ± 3.00), the probiotic group showed a significant improvement in MMSE scores (+27.90% ± 8.07, P < 0.001). Probiotic intake also led to significant favorable changes in plasma malondialdehyde, serum hs-CRP, HOMA-IR, beta cell function, serum triglycerides, and QUICKI compared with control (all P < 0.01). No considerable effects were observed on fasting plasma glucose, other lipid profiles, or other biomarkers of oxidative stress and inflammation.
NANO counterpoint →
Akbari E, Asemi Z, Daneshvar Kakhaki R, et al. Front Aging Neurosci, 2016. PMID 27891089
2016 / Randomized controlled trial
Forty-five women aged 63-79 years with osteopenia or osteoporosis were randomly assigned to 12 weeks of Nordic walking training (3 times a week) or a control group. The training group showed significant increases in skeletal muscle mass (P=0.007), skeletal muscle index (P=0.007), knee extensor strength index (P=0.016), knee flexor strength index (P<0.001), functional mobility (P<0.001), and functional performance (P<0.001). Body mass (P=0.006), BMI (P<0.001), and percent body fat (P<0.001) significantly decreased, while handgrip strength showed no improvement (P=0.315). No significant changes occurred in the control group.
Ossowski ZM, Skrobot W, Aschenbrenner P, et al. Clin Interv Aging, 2016. PMID 27942207
2016 / Two randomized controlled trials
Two randomized controlled trials evaluated the effects of flavonoid interventions on serum BDNF and cognitive function. In Trial 1, an 18-week intervention with high-flavonoid fruit and vegetables, but not low-flavonoid, induced significant improvements in cognitive performance and increases in serum BDNF (p < 0.001). In Trial 2, a high-flavanol cocoa drink (494 mg total flavanols) for 12 weeks also significantly increased serum BDNF (p < 0.001), which correlated with improvements in global cognitive performance.
Neshatdoust S, Saunders C, Castle SM, et al. Nutr Healthy Aging, 2016. PMID 28035345
2016 / Double-blind, placebo-controlled, randomized trial
Sixty patients with wet or dry AMD were randomized to receive oral saffron 30 mg/day or placebo for 6 months. In dry AMD, no statistically significant difference in OCT results was seen at 6 months (P = 0.282), though ERG results significantly increased between groups at 3 months (P = 0.027). In wet AMD, OCT results decreased significantly between groups at follow-up (P = 0.05), and ERG findings increased significantly at 3 months (P = 0.01), though this ERG change decreased by 6 months (P = 0.213).
Lashay A, Sadough G, Ashrafi E, et al. Med Hypothesis Discov Innov Ophthalmol, 2016. PMID 28289690
2015 / Double-blind randomised placebo-controlled clinical trial
A 2-year trial randomized 605 participants with knee osteoarthritis to once-daily glucosamine sulfate (1500 mg), chondroitin sulfate (800 mg), both supplements, or placebo. After adjusting for structural disease progression factors, the combination group showed a statistically significant reduction in 2-year JSN versus placebo (mean difference 0.10 mm, 95% CI 0.002 mm to 0.20 mm; p=0.046), whereas single treatments showed no significant structural effect. All four groups had reduced knee pain over the first year, with no significant between-group differences (p=0.93). Overall, 34 (6%) participants reported possibly-related adverse medical events over 2 years.
Fransen M, Agaliotis M, Nairn L, et al. Ann Rheum Dis, 2015. PMID 24395557
2015 / Randomized controlled trial (secondary analysis)
In a 6-month trial, 86 women aged 70-80 years with probable mild cognitive impairment were randomly assigned to twice-weekly aerobic training (AT), resistance training (RT), or balance and tone training (BAT, control). Compared with BAT, AT significantly improved left, right, and total hippocampal volumes (p<=0.03). After adjusting for baseline cognitive function and experimental group, increased left hippocampal volume was independently associated with reduced verbal memory and learning performance indexed by loss after interference (r=0.42, p=0.03).
ten Brinke LF, Bolandzadeh N, Nagamatsu LS, et al. Br J Sports Med, 2015. PMID 24711660
2015 / Interventional crossover controlled prospective trial
A crossover trial in 35 healthy elderly individuals evaluated the effects of 4 daily placebo maltodextrin 'tea-bags' for 12 weeks followed by four 1.5 g daily green tea bags for 12 weeks. Green tea did not alter erythrocyte catalase activity, saliva oral peroxidase enzymes, or plasma oxidative markers (protein carbonyls, lipid peroxides, and TBARS). However, AAPH-induced oxidative hemolysis declined by 10.2% (p<0.001) and saliva total antioxidant capacity increased by 42.0% (p<0.01). The clinical implications of these oxidative changes require further research.
Narotzki B, Reznick AZ, Mitki T, et al. Adv Exp Med Biol, 2015. PMID 25300686
2015 / Randomized clinical trial
Older adults with moderate sleep disturbances were randomized to a 6-week mindful awareness practices (MAPs, n=24) or sleep hygiene education (SHE, n=25) intervention. In intent-to-treat analysis, the MAPs group showed significant improvement on the PSQI compared to the SHE group (between-group mean difference 1.8 [95% CI, 0.6-2.9], effect size 0.89), with postintervention scores of 7.4 (1.9) vs 9.1 (2.0). MAPs also led to significant improvements over SHE in insomnia symptoms, depression symptoms, fatigue interference, and fatigue severity (P < .05 for all), while anxiety, stress, and NF-κB showed no between-group differences.
Black DS, O'Reilly GA, Olmstead R, et al. JAMA Intern Med, 2015. PMID 25686304
2015 / Double-blind cross-over trial
In a double-blind cross-over study, the sleep of 22 young and 24 middle-aged adults was recorded using polysomnography under placebo and caffeine conditions (200 mg and 400 mg). Compared to placebo, caffeine increased sleep latency, shortened total sleep duration, and reduced sleep efficiency, with effects at the 400 mg dose being more pronounced in middle-aged adults. In both age groups, caffeine dose-dependently increased relative stage 1 sleep and reduced absolute and relative slow wave sleep as well as absolute rapid eye movement sleep. The 400 mg dose increased absolute stage 1 sleep in young adults but decreased absolute stage 2 sleep in middle-aged adults.
Robillard R, Bouchard M, Cartier A, et al. J Psychopharmacol, 2015. PMID 25759402
2015 / Randomized controlled trial
In a 2-year randomized trial of 409 older women, neither 800 IU daily vitamin D nor exercise reduced overall fall rates (118.2 to 132.1 falls per 100 person-years across groups). However, injurious fall rates were significantly lower with exercise plus vitamin D (hazard ratio 0.38; 95% CI, 0.17-0.83) and exercise alone (hazard ratio 0.47; 95% CI, 0.23-0.99). Vitamin D maintained bone density, but only exercise enhanced physical functioning.
Uusi-Rasi K, Patil R, Karinkanta S, et al. JAMA Intern Med, 2015. PMID 25799402
2015 / Clinical trial
This study evaluated the effects of flaxseed on menopausal symptoms and quality of life in 140 menopausal women divided into four groups at a university hospital outpatient department. Women who consumed flaxseed for 3 months experienced a decrease in menopausal symptoms and an increase in quality of life.
Cetisli NE, Saruhan A, Kivcak B Holist Nurs Pract, 2015. PMID 25882265
2015 / Randomized controlled trial
In a six-week trial, older adults aged over 60 consumed either two cups of frozen blueberries daily or a carrot-based control beverage. Compared with the control drink, blueberry supplementation led to significant reductions in step errors during a challenging dual-task adaptive gait assessment. Within the blueberry cohort, participants also showed significant gains in usual walking pace, single-task step accuracy, and dual-task movement speed.
Schrager MA, Hilton J, Gould R, et al. Appl Physiol Nutr Metab, 2015. PMID 25909473
2015 / 5-year register-based follow-up of a 1-year randomized controlled trial
This 5-year register-based follow-up evaluated 145 older women who completed a 1-year, four-arm randomized controlled trial of exercise. Over follow-up, 81 injurious falls including 26 fractures occurred. Compared with controls, the combined resistance and balance-jumping exercise (COMB) group had a 62% lower rate of injured fallers (HR 0.38, 95% CI 0.17 to 0.85), 51% fewer injurious falls (RR 0.49, 95% CI 0.25 to 0.98), and 74% fewer fractures (RR 0.26, 95% CI 0.07 to 0.97). The authors note these long-term effects need to be confirmed in future studies.
Karinkanta S, Kannus P, Uusi-Rasi K, et al. Age Ageing, 2015. PMID 25990940
2015 / Experimental animal study and pilot clinical trial
Cycles of a fasting mimicking diet extended lifespan, stimulated stem cell regeneration upon re-feeding, reduced visceral fat, decreased cancer incidence, and improved cognitive performance in mice. In a pilot clinical trial, three cycles of the fasting mimicking diet decreased risk factors and biomarkers associated with aging, diabetes, cardiovascular disease, and cancer without causing major adverse effects.
Brandhorst S, Choi IY, Wei M, et al. Cell Metab, 2015. PMID 26094889
2015 / Randomized clinical trial
Fifty-seven healthy postmenopausal women were randomized to consume either 500 ml/day of soy milk (containing genistein and daidzein, n = 34) or 500 ml/day of low-fat cow milk (control, n = 23) for 8 months, with both groups taking daily calcium-D capsules. Quality of life was evaluated using the MENQOL questionnaire at baseline and month 8. A significant but weak difference was observed between groups in the sexual domain score (mean percent change: 0.46% in soy milk vs. 33.94% in control; p = 0.031), while a significant relationship was found between soy milk consumption and improvement in vasomotor, psychosocial, and physical domains. The authors concluded overall that soy milk does not improve quality of life in postmenopausal women.
Nourozi M, Haghollahi F, Ramezanzadeh F, et al. J Family Reprod Health, 2015. PMID 26175764
2015 / Randomized controlled trial
In a 2-year trial, 218 nonobese adults aged 21-51 years were randomized to 25% caloric restriction or ad libitum diet. The restriction group achieved 11.7% calorie reduction and sustained 10.4% weight loss. Triiodothyronine decreased significantly more in the restricted group at 12 and 24 months (P<0.001), while weight-adjusted resting metabolic rate fell significantly more at 12 months (P=0.04) but not at 24 months. Core temperature was unchanged, and cardiometabolic risk factors decreased without harming quality of life.
Ravussin E, Redman LM, Rochon J, et al. J Gerontol A Biol Sci Med Sci, 2015. PMID 26187233